CVS Corp (CVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 7,192,000 | 6,631,000 | -596,000 | 6,623,000 | 5,319,000 |
| Depreciation Amortization | 4,441,000 | 4,371,000 | 8,867,000 | 2,660,000 | 2,475,000 |
| Income taxes - deferred | -570,000 | -654,000 | 87,000 | -1,334,000 | 18,000 |
| Accounts receivable | -1,510,000 | -2,158,000 | -1,139,000 | -941,000 | -243,000 |
| Accounts payable and accrued liabilities | 2,769,000 | 3,550,000 | 2,329,000 | 1,710,000 | 2,189,000 |
| Other Working Capital | 3,159,000 | 1,499,000 | -112,000 | -416,000 | 1,329,000 |
| Other Operating Activity | 384,000 | -391,000 | -571,000 | -295,000 | -946,000 |
| Operating Cash Flow | $15,865,000 | $12,848,000 | $8,865,000 | $8,007,000 | $10,141,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -9,639,000 | -7,534,000 | N/A | N/A | -80,000 |
| PPE Investments | -2,437,000 | -2,457,000 | -2,037,000 | -1,918,000 | -2,224,000 |
| Net Acquisitions | -26,000 | -444,000 | -41,394,000 | -1,181,000 | -524,000 |
| Purchase Of Investment | N/A | N/A | -692,000 | -137,000 | N/A |
| Sale Of Investment | 6,467,000 | 7,049,000 | 817,000 | 61,000 | 91,000 |
| Other Investing Activity | 101,000 | 47,000 | 21,000 | 298,000 | 267,000 |
| Investing Cash Flow | $-5,534,000 | $-3,339,000 | $-43,285,000 | $-2,877,000 | $-2,470,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 1,874,000 |
| Debt Issued | 9,958,000 | 3,736,000 | 44,343,000 | 0 | 3,455,000 |
| Debt Repayment | -15,631,000 | -8,336,000 | -5,522,000 | 0 | -5,943,000 |
| Common Stock Issued | 264,000 | 210,000 | 242,000 | 329,000 | 296,000 |
| Common Stock Repurchased | N/A | N/A | N/A | -4,361,000 | -4,461,000 |
| Dividend Paid | -2,624,000 | -2,603,000 | -2,038,000 | -2,049,000 | -1,840,000 |
| Other Financing Activity | 337,000 | -661,000 | -206,000 | -670,000 | -142,000 |
| Financing Cash Flow | $-7,696,000 | $-7,654,000 | $36,819,000 | $-6,751,000 | $-6,761,000 |
| Exchange Rate Effect | N/A | N/A | -4,000 | 1,000 | 2,000 |
| Beginning Cash Position | 8,408,000 | 6,553,000 | 1,900,000 | 3,520,000 | 2,608,000 |
| End Cash Position | 11,043,000 | 8,408,000 | 4,295,000 | 1,900,000 | 3,520,000 |
| Net Cash Flow | $2,635,000 | $1,855,000 | $2,395,000 | $-1,620,000 | $912,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 15,865,000 | 12,848,000 | 8,865,000 | 8,007,000 | 10,141,000 |
| Capital Expenditure | -2,437,000 | -2,457,000 | -2,037,000 | -1,918,000 | -2,224,000 |
| Free Cash Flow | 13,428,000 | 10,391,000 | 6,828,000 | 6,089,000 | 7,917,000 |